Barriers and facilitators for family physicians prescribing opioid agonist therapy in Saskatchewan

被引:0
|
作者
Nguyen, Teresa [1 ]
Bareham, Julia [2 ]
Halpape, Katelyn [3 ]
机构
[1] Loblaw Pharm Saskatoon, Saskatoon, SK, Canada
[2] Univ Saskatchewan, RxFiles Acad Detailing Program, Saskatoon, SK, Canada
[3] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada
关键词
COLLABORATIVE CARE; BUPRENORPHINE; EXPERIENCE; ABSTINENCE; ADDICTION; METHADONE;
D O I
10.46747/cfp.7004e52
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To explore barriers and facilitators for family physicians in Saskatchewan prescribing opioid agonist therapy (OAT). Design Self-administered postal survey. Setting Family medicine practices in Saskatchewan. Participants A total of 218 Saskatchewan family physicians who were not authorized to prescribe OAT as of June 2022. Main outcome measures Descriptive and inferential statistics of physicians' self-reported barriers to and facilitators of prescribing OAT for opioid use disorder (OUD). Results Most respondents (84.8%) had some comfort with diagnosing OUD. However, more than half (58.3%) did not feel confident or knowledgeable about prescribing OAT. Barriers to OAT prescribing included lack of time, incomplete training requirements, lack of interest, insufficient funding or support, feeling overwhelmed, and perceiving that OAT does not work and thus is not necessary. Physicians working in core neighbourhoods and those receiving fee-for-service compensation reported the least available time to prescribe OAT. Conversely, physicians working in interdisciplinary team settings had increased time for OAT prescribing compared with physicians in other settings. Having a close personal relationship with someone with OUD was correlated with increased comfort in diagnosing OUD as well as with knowledge about and confidence in prescribing OAT. Themes identified as facilitators to increasing OAT prescribing included the addition of resources and supports, increased training, more awareness about OUD and OAT, enhanced compensation, and altered prescribing regulations. Conclusion Despite the presence of several real and perceived barriers limiting OAT prescribing by Saskatchewan family physicians, there are family physicians interested in providing this therapy. Increased clinical resources and support, including increased interdisciplinary practice, are actionable steps that should be considered by policy decision makers to address this issue. Additionally, increased OUD and OAT education, which includes the perspectives of those with lived experience of OUD, would help address physician confidence, knowledge, and awareness in this area.
引用
收藏
页码:e52 / e60
页数:9
相关论文
共 50 条
  • [1] Barriers and facilitators to office-based opioid agonist therapy prescribing and effective interventions to increase provider prescribing: protocol for a systematic review
    Lara L. Nixon
    Jazmin C. Marlinga
    K. Alix Hayden
    Kelly J. Mrklas
    Systematic Reviews, 8
  • [2] Barriers and facilitators to office-based opioid agonist therapy prescribing and effective interventions to increase provider prescribing: protocol for a systematic review
    Nixon, Lara L.
    Marlinga, Jazmin C.
    Hayden, K. Alix
    Mrklas, Kelly J.
    SYSTEMATIC REVIEWS, 2019, 8 (1)
  • [3] A Cross-sectional Study of Opioid Agonist Therapy Barriers and Facilitators
    Duff, Elsie
    Fehr, Cindy
    Shams, Shahid
    Wintoniw, Steven
    Devenney, Ashley
    Ashfield, Diana
    O'Rourke, Tammy
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2024, 20 (04):
  • [4] EMERGENCY PHYSICIANS' PERCEPTION OF BARRIERS AND FACILITATORS FOR ADOPTING AN OPIOID PRESCRIBING GUIDELINE IN OHIO: A QUALITATIVE INTERVIEW STUDY
    Penm, Jonathan
    MacKinnon, Neil J.
    Connelly, Chloe
    Mashni, Rebecca
    Lyons, Michael S.
    Hooker, Edmond A.
    Winstanley, Erin L.
    Carlton-Ford, Steve
    Tolle, Erica
    Boone, Jill
    Koechlin, Kathleen
    Defiore-Hyrmer, Jolene
    JOURNAL OF EMERGENCY MEDICINE, 2019, 56 (01): : 15 - 22
  • [5] Perceived barriers related to the management of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE Study
    Litwin, Alain H.
    Drolet, Martine
    Nwankwo, Chizoba
    Torrens, Marta
    Kastelic, Andrej
    Walcher, Stephan
    Somaini, Lorenzo
    Mulvihill, Emily H.
    Ertl, Jochen
    Grebely, Jason
    HEPATOLOGY, 2017, 66 : 568A - 569A
  • [6] Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review
    Em M. Pijl
    Abeer Alraja
    Elsie Duff
    Carol Cooke
    Stephen Dash
    Nichole Nayak
    Jesse Lamoureux
    Ginette Poulin
    Erin Knight
    Ben Fry
    Substance Abuse Treatment, Prevention, and Policy, 17
  • [7] Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review
    Pijl, Em M.
    Alraja, Abeer
    Duff, Elsie
    Cooke, Carol
    Dash, Stephen
    Nayak, Nichole
    Lamoureux, Jesse
    Poulin, Ginette
    Knight, Erin
    Fry, Ben
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2022, 17 (01)
  • [8] Facilitators and Barriers to Expedited Partner Therapy: Results From a Survey of Family Physicians
    Wong, Jason
    Zakher, Bernadette
    Consolacion, Theodora
    Leong, Jeffrey
    Choi, Alexandra
    Prescott, Cheryl
    Ng, Brian
    Pawa, Jasmine
    Campbell, Audrey
    SEXUALLY TRANSMITTED DISEASES, 2020, 47 (08) : 525 - 529
  • [9] Family Physicians' Barriers and Facilitators in Incorporating Medication Abortion
    Razon, Na'amah
    Wulf, Sarah
    Perez, Citlali
    McNeil, Sarah
    Maldonado, Lisa
    Fields, Alison Byrne
    Holt, Kelsey
    Fox, Edith
    Silverstein, Ilana
    Dehlendorf, Christine
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2022, 35 (03) : 579 - 587
  • [10] Barriers to and facilitators of opioid prescribing by dentists in the United States A qualitative study
    Yan, Connie H.
    Ramanathan, Swetha
    Suda, Katie J.
    Khouja, Tumader
    Rowan, Susan A.
    Evans, Charlesnika T.
    Lee, Todd A.
    Calip, Gregory S.
    Gellad, Walid F.
    Sharp, Lisa K.
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2022, 153 (10): : 957 - +